BIT Capital’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-9,147
Closed -$813K 104
2026
Q1
$813K Buy
+9,147
New +$940K 0.04% 64
2025
Q3
Sell
-96,089
Closed -$10.2M 113
2025
Q2
$10.2M Buy
96,089
+85,503
+808% +$8.64M 0.59% 34
2025
Q1
$964K Sell
10,586
-8,894
-46% -$996K 0.08% 61
2024
Q4
$2.22M Buy
19,480
+2,370
+14% +$270K 0.18% 53
2024
Q3
$2.03M Buy
+17,110
New +$1.57M 0.19% 48
2022
Q1
Sell
-5,550
Closed -$1.43M 161
2021
Q4
$1.43M Sell
5,550
-11,629
-68% -$3.18M 0.11% 71
2021
Q3
$4.69M Buy
17,179
+8,929
+108% +$2.84M 0.27% 34
2021
Q2
$1.85M Hold
8,250
0.11% 54
2021
Q1
$901K Buy
+8,250
New +$876K 0.07% 53

Other funds holding BNTX

BIT Capital's BNTX Position: Q2 2026 in Review

BIT Capital sold out of BioNTech (BNTX) in Q2 2026, closing a stake of 9,147 shares — an estimated $813K sold.

BIT Capital first reported a position in BNTX in Q1 2021 and held it in 9 quarters. The position peaked at $10.2M in Q2 2025. 281 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

  • BIT Capital reported no remaining BioNTech position as of Q2 2026 after selling out during the quarter.
  • BIT Capital sold 9,147 BioNTech shares in Q2 2026, an estimated $813K.
  • BIT Capital first reported a position in BioNTech in Q1 2021 and held it in 9 quarters.
  • BIT Capital's BioNTech position peaked at $10.2M in Q2 2025.
  • 281 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on BIT Capital's 13F filing for Q2 2026, filed 12 Aug 2026.